Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy

por Gale, Jeremy D., Gilbert, Steven, Blumenthal, Samuel, Elliott, Tom, Pergola, Pablo E., Goteti, Kosalaram, Scheele, Wim, Perros-Huguet, Christelle
Publicado 2018

Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects

por Singh, Dave, Siew, Leonard, Christensen, Jared, Plumb, Jonathan, Clarke, Graham W., Greenaway, Steve, Perros-Huguet, Christelle, Clarke, Nick, Kilty, Iain, Tan, Lisa
Publicado 2015